ArticleCell death & disease2023

AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway.

Liming Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.